Continuous glucose monitor for type 2 diabetes in pregnancy
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are between 4 and 26 weeks pregnant with a single baby.
- Your blood sugar is not well controlled (high fasting or after-meal levels) despite diet or a background insulin.
- You need either mealtime insulin or an insulin pump for your diabetes management.
- You are willing to receive prenatal care at one of the hospitals in Beijing (Peking University Third Hospital, Haidian, or Yanqing District Hospital).
- You do not have severe diabetes complications (like advanced eye, kidney, or heart disease) or other conditions requiring steroid or immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This study tests whether using a continuous glucose monitor during pregnancy is useful for people with type 2 diabetes. It may help track blood sugar levels more closely to support safer pregnancy care.
This trial tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks your blood sugar all the time — helps pregnant women with type 2 diabetes manage their sugar levels. If you take part, you will get a CGM and regular care; the goal is to see if CGM leads to better health for you and your baby.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This study uses a continuous glucose monitor to check blood sugar levels after giving birth in people who had gestational diabetes. It aims to find early signs of abnormal blood sugar and may help you understand your risk for type 2 diabetes.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Hear when a new Type2diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.